Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Antimicrob Chemother ; 59(6): 1076-83, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17468115

RESUMEN

OBJECTIVES: A patient with Candida albicans thrush and oesophagitis was treated with high doses of caspofungin but treatment eventually failed. Four C. albicans isolates were serially recovered before and after caspofungin treatment. A microbiological study was performed to characterize these four isolates. METHODS: In vitro antifungal susceptibility testing was performed by the EUCAST reference method in RPMI and AM3 and by Etest. Molecular typing of the four isolates was done by sizing three polymorphic microsatellite markers. To look for specific mutations, sequencing of a region of the gene encoding the 1-3-beta-D-glucan synthase was performed for the four isolates. RESULTS: In vitro antifungal susceptibility testing showed an increase in both caspofungin and micafungin MICs for the two isolates recovered after caspofungin treatment failure. The best discrimination between the pre-treatment and post-treatment isolates was obtained with Etest. Molecular typing of the four isolates showed that the post-treatment isolates with reduced susceptibility were identical to a susceptible pre-treatment isolate, suggesting the acquisition of caspofungin resistance. Sequencing of the gene encoding the 1-3-beta-D-glucan synthase showed a mutation responsible for an amino acid change at Phe-641 that could confer reduced susceptibility to both echinocandins. CONCLUSIONS: Our results indicate that is it useful to perform in vitro susceptibility testing in the cases of clinical failure during caspofungin therapy.


Asunto(s)
Antifúngicos/farmacología , Candida albicans/efectos de los fármacos , Candidiasis/tratamiento farmacológico , Farmacorresistencia Fúngica/fisiología , Lipoproteínas/farmacología , Péptidos Cíclicos/farmacología , Adulto , Secuencia de Aminoácidos , Sustitución de Aminoácidos , Anfotericina B/farmacología , Antifúngicos/uso terapéutico , Candidiasis/microbiología , Caspofungina , Equinocandinas , Fluconazol/farmacología , Genotipo , Infecciones por VIH/complicaciones , VIH-1 , Humanos , Lipopéptidos , Lipoproteínas/uso terapéutico , Masculino , Micafungina , Pruebas de Sensibilidad Microbiana , Datos de Secuencia Molecular , Péptidos Cíclicos/uso terapéutico , Pirimidinas/uso terapéutico , Insuficiencia del Tratamiento , Triazoles/uso terapéutico , Voriconazol
2.
Rev Med Interne ; 27(7): 546-9, 2006 Jul.
Artículo en Francés | MEDLINE | ID: mdl-16678940

RESUMEN

INTRODUCTION: Adult onset Still's disease is a systemic inflammatory disorder of unknown etiology characterized by the association of a high spiking fever, an evanescent skin rash, arthritis, and hyperleukocytosis. Pericarditis is amongst the most common systemic manifestations of adult onset Still's disease. EXEGESIS: We report on two patients with a pericardial tamponade revealing an adult onset Still's disease in a 52-year-old female and a 31-year-old male. Pericardial fluid was bloody in the two cases, and histopathology only disclosed non specific inflammatory changes. Both patients received corticosteroids and outcome was uneventful with a follow-up of 8 years and 12 months, respectively. CONCLUSION: Pericardial tamponade is an uncommon clinical feature of adult-onset Still's disease and usually occurs at disease onset. It makes the diagnosis of adult-onset Still's disease difficult as the other disease manifestations are commonly neglected. Adult onset Still's disease should be added to the differential of acute pericarditis and tamponade.


Asunto(s)
Taponamiento Cardíaco/diagnóstico , Enfermedad de Still del Adulto/diagnóstico , Adulto , Antiinflamatorios/uso terapéutico , Femenino , Estudios de Seguimiento , Glucocorticoides/uso terapéutico , Humanos , Masculino , Persona de Mediana Edad , Derrame Pericárdico/diagnóstico , Pericarditis/diagnóstico , Prednisona/uso terapéutico , Enfermedad de Still del Adulto/tratamiento farmacológico
4.
Clin Infect Dis ; 41(2): e22-6, 2005 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-15983907

RESUMEN

Diffuse infiltrative lymphocytosis syndrome (DILS) in patients with human immunodeficiency virus (HIV) infection is characterized by persistent CD8(+) lymphocytosis with visceral lymphocytic infiltration. DILS induces a large spectrum of clinical features. We describe 2 HIV-infected patients with upper respiratory tract involvement that occurred during the course of DILS.


Asunto(s)
Infecciones por VIH/complicaciones , Linfocitosis/etiología , Enfermedades Respiratorias/etiología , Adulto , Fármacos Anti-VIH/uso terapéutico , Linfocitos T CD8-positivos , Femenino , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/virología , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA